Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.
Product
oracle pharmaceutical vulnerabilities
2 published CVES affecting oracle pharmaceutical, from public sources (CVE.org, NVD, CISA KEV, FIRST EPSS, OSV).
- Total
- 2
- Critical
- 0
- High
- 2
- Medium
- 0
- Low
- 0
- Unscored
- 0
- CISA KEV
- 0
Latest oracle pharmaceutical CVEs
Newest publication first
-
HighCVSS 10.0 EPSS 4.5%
-
HighCVSS 10.0 EPSS 4.6%
Unspecified vulnerability in the Oracle Thesaurus Management System component in Oracle E-Business Suite and OPA 4.5.2 Applications has unknown impact and attack vectors, aka Vuln# OPA01.
Sources: CVE.org, NVD, CISA KEV, FIRST EPSS, OSV and public exploit-reference metadata. Product matching comes from the published CVE records. A proof-of-concept means public code exists; it is not evidence of exploitation.